EGFR and neoplasm: We therefore decided to synthesize fluorescein labeled SiO2-NPs tagged with anti-EGF-receptor-antibodies (EGFR-SiO2-NPs) and evaluated this novel contrast agent for tumor specific targeting in an ex vivo model system.